PIRIBEDIL (ET 495) IN THE TREATMENT OF PARKINSON'S DISEASE COMBINED WITH AMANTADINE OR LEVODOPA
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1975.tb05772.x/fullpdf
Reference14 articles.
1. Treatment of Parkinson's Disease with Levodopa and Amantadine used as single drugs and in combined therapy;Callaghan;Irish J. med. Sci.,1974
2. An extended clinical trial to compare Levodopa and Amantadine used as single drugs with both drugs used in combination in Parkinson's Disease;Callaghan;Irish J. med. Sci.,1974
3. Bromocriptine in Parkinson's Disease;Calne;Brit. med. J.,1974
4. Evidence for a new type of dopamine receptor stimulating agent;Corrodi;J. Pharm. Pharmacol.,1971
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The agonist of dopamine receptors piribedil in treatment of Parkinson’s disease;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2017
2. Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease;CNS Drugs;2016-06-25
3. Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders;Current Drug Therapy;2011-02-01
4. From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease;Pharmacology & Therapeutics;2010-11
5. The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease;Movement Disorders;2005-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3